CFTR and cystic fibrosis: Regarding novel therapeutics for CF, several challenges need to be overcome with the development of drugs that restore the CFTR function in all people with CF, regardless of CFTR genotype, in order to prevent or delay irreversible damage of the lungs and compromisation of the nutritional status.